
Sign up to save your podcasts
Or


GSD Presents sponsored by Runday.ai Revolutionary Cancer Cures with Sumit Rai Sept. 03 About Guest:
Sumit Rai, Chairman, CEO & Founder, Cancer Check Labshttps://www.linkedin.com/in/raisumit/
About Sumit:
Mr. Rai is the founder and CEO of Cancer Check Labs, where his innovative approach to circulating tumor cell (CTC) capture is transforming cancer technology. Driven by the loss of his younger sister to cancer, Mr. Rai is dedicated to the fight against the disease. Since 2012, he has served as President of Cure Sonia, which funds cancer research at top centers like Stanford, USC, and MD Anderson, and provides financial assistance to families in need. He also recently launched Save A Firefighter, offering early cancer detection for firefighters who face triple the cancer risk due to their occupation. In 2022, Mr. Rai was nominated for the National Board of the Leukemia & Lymphoma Society. Before his work in cancer research, Mr. Rai spent 20 years in venture capital, private equity, and hedge funds as well as founding a mobile ad exchange with a notable exit. #GSDPresents #CancerCures #SumitRai #RevolutionaryMedicine #CancerResearch #HealthcareInnovation #MedicalBreakthroughs #OncologyAdvancements #FightCancer
By Gary FowlerGSD Presents sponsored by Runday.ai Revolutionary Cancer Cures with Sumit Rai Sept. 03 About Guest:
Sumit Rai, Chairman, CEO & Founder, Cancer Check Labshttps://www.linkedin.com/in/raisumit/
About Sumit:
Mr. Rai is the founder and CEO of Cancer Check Labs, where his innovative approach to circulating tumor cell (CTC) capture is transforming cancer technology. Driven by the loss of his younger sister to cancer, Mr. Rai is dedicated to the fight against the disease. Since 2012, he has served as President of Cure Sonia, which funds cancer research at top centers like Stanford, USC, and MD Anderson, and provides financial assistance to families in need. He also recently launched Save A Firefighter, offering early cancer detection for firefighters who face triple the cancer risk due to their occupation. In 2022, Mr. Rai was nominated for the National Board of the Leukemia & Lymphoma Society. Before his work in cancer research, Mr. Rai spent 20 years in venture capital, private equity, and hedge funds as well as founding a mobile ad exchange with a notable exit. #GSDPresents #CancerCures #SumitRai #RevolutionaryMedicine #CancerResearch #HealthcareInnovation #MedicalBreakthroughs #OncologyAdvancements #FightCancer